Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 2, 2001, Pages

  Franz, A R ^a   Pohlandt, F ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Erythrocyte; Erythropoietin; Packed cell volume; Preterm; Red blood cell; Transfusion

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; META ANALYSIS; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 0035085865     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.84.2.f96     Document Type: Article

References (46)

1. Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects
2. Changing patterns of red blood cell transfusion in very low birth weight infants
3. Optimizing the approach to anemia in the preterm infant: Is there a role for erythropoietin therapy?
4. Red blood cell transfusions for preterm infants: The role of evidence-based medicine
5. Variations in blood transfusions among newborn intensive care units SNAP II Study Group
6. Variations in transfusion practice in neonatal intensive care
7. Blood transfusion. Iron load and retinopathy of prematurity
8. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
9. Antioxidant activity, packed cell transfusions, and outcome in premature infants
10. Blood transfusion and chronic lung disease in preterm infants
11. Recombinant erythropoietin for the anemia of prematurity: Still a promise, not a panacea
12. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the anemia of prematurity
13. Circulating erythroid progenitors in the anemia of prematurity
14. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematuriry
15. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot study
16. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
17. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study
18. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity
19. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group
20. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, doubleblind, placebo-controlled study
21. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study
22. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants
23. Red blood cell transfusion practices in the neonate
24. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams
25. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group
26. Umbilical venous erythropoietin and umbilical arterial pH in relation to morphologic placental abnormalities
27. Impact of transfusion guidelines on neonatal transfusions
28. Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants
29. At what age does iron supplementation become necessary in low-birth weight infants?
30. Haemoglobin concentration depends on protein intake in small preterm infants fed human milk
31. Parenteral iron increases serum erythropoietin concentration during the early anaemia of 10-20-day-old mice
32. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematuriry
33. Assessment of anemia in newborn infants
34. Recombinant human erythropoietin in neonatal anemia
35. Factors related to transfusion in very low birthweight infants treated with erythropoietin
36. Low degree of regionalization and high transfusion rates in very low birthweight infants: A survey in Germany
37. Total circulating red cells versus haematocrit as the primary descriptor of oxygen transport by the blood
38. Red cell volume and cardiac output in anaemic preterm infants
39. Peripheral oxygenation and anemia in preterm babies
40. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia
41. The role of RBC transfusion in the premature infant
42. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia
43. Haematocrit and red blood cell transport in preterm infants: An observational study
44. The critical hemoglobin value in newborn infants, infants and children
45. Guidelines for auditing pediatric blood transfusion practices
46. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994